Morbius Director Daniel Espinosa Thinks He Was The Wrong Person For The Job

by

Morbius Director Daniel Espinosa Thinks He Was The Wrong Person For The Job

Highlights

  • Morbius underperformed at the box office, with director Espinosa admitting he wasn’t the best fit for the project.
  • Compared to successful Marvel movies like Venom, Morbius fell short in ticket sales and critical reception.
  • Characterization issues and poor reviews plagued Morbius, making it unlikely for a sequel despite post-credit scenes hinting at one.

As a gamer with a keen eye for movies and a soft spot for Marvel, I can’t help but feel disappointed by Sony and Marvel’s offering of Morbius. Having enjoyed director Daniel Espinosa‘s previous works such as Life, Child 44, Safe House, and Easy Money, I had high hopes for the film adaptation of Morbius. However, it seems that even the Swedish mastermind wasn’t the best fit for this project.

The film “Morbius” underperformed at the cinema, earning a place among Marvel’s less successful productions. In fact, its director, Daniel Espinosa, acknowledged that perhaps he wasn’t the ideal choice for directing this particular movie.

Espinosa is a Swedish filmmaker who has directed, produced, and written movies. Some of his most recognized works include the horror-sci-fi movie “Life” (2017), the crime thriller “Child 44” (2015), the action thriller “Safe House” (2012), and the crime thriller “Easy Money” (2010). In June 2018, Espinosa was hired to direct Sony and Marvel’s “Morbius,” starring Jared Leto. The movie faced numerous delays before its release in 2022. Although fans were eagerly waiting, the film underperformed at the box office, received poor reviews from critics, and failed to keep audiences interested during its run. In a statement made two years after the movie’s release, Espinosa admitted that he may not have been the best choice for directing “Morbius.”

During an interview at the Taormina Film Festival, where his movie Madame Luna was shown, Espinosa was questioned about the poor box office performance of Morbius. The director admitted that he was impacted by this, stating that making a film through committee can be challenging. He suggested that perhaps another director might have been more suitable for the project due to creative differences that may have influenced the movie’s overall production. Espinosa also mentioned that he is known in studios as someone with strong opinions, which could explain why they may not have sought him for this specific role.

The film titled Morbius, which had an initial budget of $75 million, struggled to generate $39.1 million during its opening weekend. This underperformance fell significantly short compared to the debuts of both 2018’s Venom ($80 million) and its sequel Let There Be Carnage in 2021 ($90 million). Moreover, the film experienced a substantial 74% drop in revenue during its second weekend. The disappointing performance of Morbius led many experts to conclude that fans don’t solely attend cinemas due to its association with Marvel. Instead, they are also concerned about whether the movie offers good value for money. As Shawn Robbins, chief analyst at Box Office Pro, pointed out, “The Marvel brand has a strong appeal for audiences, but this appeal comes with a responsibility to produce films that entertain and meet certain standards. Audiences are intelligent, and their support for a franchise hinges on the consistent delivery of high-quality storytelling.”

As a die-hard Spider-Man fan, I’ve been excited about Sony and Marvel’s efforts to broaden the Spidey universe by delving into the villainous characters. Their debut, Venom, garnered mixed reactions from critics, but it was Tom Hardy’s captivating portrayal of Eddie Brock that truly shone. The comedic interplay between Eddie and his symbiote, Venom, kept audiences engaged and laughing, making the film relatable and entertaining. For example, in one scene, Eddie labels Venom a parasite while talking to a woman at a store, only for the symbiote to demand an apology. Although it didn’t meet all expectations, Venom wasn’t exactly a box-office bomb. In fact, it grossed $856 million against a production budget of just $100 million. Its sequel, Let There Be Carnage, managed to rake in an impressive $506 million with a slightly higher budget of $110 million.

Compared to Morbius, various aspects such as acting, rhythm, storyline, and characters felt off-kilter. No character managed to stand out or leave a lasting impression due to their lack of humor or relatability. They failed to evoke any strong feelings among fans, be it love or hate. The weak character development was likely one reason for its low ratings. Despite an initial investment of around $75 million, Morbius only managed to earn between $163 and $167 million worldwide, suggesting it wasn’t worth launching a new franchise. Fortunately, Sony and Marvel avoided a potential disaster. The post-credit scenes in Morbius suggest more to come, but given the negative reception and poor box office performance, it seems unlikely that there will be a Morbius 2.

Morbius streams on Disney Plus.

Read More

2024-08-11 21:23